(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 8.48% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Teleflex's revenue in 2026 is $3,189,988,000.On average, 15 Wall Street analysts forecast TFX's revenue for 2026 to be $162,900,587,888, with the lowest TFX revenue forecast at $154,282,678,328, and the highest TFX revenue forecast at $171,695,275,080. On average, 12 Wall Street analysts forecast TFX's revenue for 2027 to be $169,839,109,944, with the lowest TFX revenue forecast at $161,574,755,648, and the highest TFX revenue forecast at $180,401,573,456.
In 2028, TFX is forecast to generate $182,611,293,856 in revenue, with the lowest revenue forecast at $176,821,826,408 and the highest revenue forecast at $190,212,732,032.